TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
RPH Pharmaceuticals AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
230,801
|
179,807
|
140,490 |
Financial expenses |
17,903
|
21,276
|
32,436 |
Earnings before taxes |
37,196
|
50,114
|
-2,661 |
EBITDA |
74,522
|
53,698
|
32,714 |
Total assets |
300,680
|
387,616
|
220,939 |
Current assets |
94,723
|
219,358
|
73,417 |
Current liabilities |
255,287
|
330,678
|
171,657 |
Equity capital |
42,471
|
51,199
|
43,543 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
14.1%
|
13.2%
|
19.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
16.1%
|
27.9%
|
-1.9% |
Return on assets (ROA) |
18.3%
|
18.4%
|
13.5% |
Current ratio |
37.1%
|
66.3%
|
42.8% |
Return on equity (ROE) |
87.6%
|
97.9%
|
-6.1% |
Change turnover |
50,994
|
39,317
|
-37,658 |
Change turnover % |
28%
![]() |
28%
|
-21% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.